Citigroup Maintains Neutral on Eastman Chemical, Lowers Price Target to $75
Citigroup analyst PJ Juvekar maintains Eastman Chemical (NYSE:EMN) with a Neutral and lowers the price target from $80 to $75.
Honeywell To $194? Plus Citigroup Slashes PT On This Stock By Over 93%
Daiwa Capital slashed the price target on Honeywell International Inc. (NYSE: HON) from $206 to $194. Honeywell shares fell 0.6% to $203.79 in pre-market trading.
Earnings Scheduled For October 27, 2022
Companies Reporting Before The Bell
• Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.
Goldman Sachs Initiates Coverage On Eastman Chemical with Neutral Rating, Announces Price Target of $78
Goldman Sachs analyst Duffy Fischer initiates coverage on Eastman Chemical (NYSE:EMN) with a Neutral rating and announces Price Target of $78.
Morgan Stanley Maintains Overweight on Eastman Chemical, Lowers Price Target to $115
Morgan Stanley analyst Vincent Andrews maintains Eastman Chemical (NYSE:EMN) with a Overweight and lowers the price target from $165 to $115.
What 14 Analyst Ratings Have To Say About Eastman Chemical
Over the past 3 months, 14 analysts have published their opinion on Eastman Chemical (NYSE:EMN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Interzero And Eastman Reach Long-Term Supply Agreement For Planned Molecular Recycling Facility In France; Up To 20,000 Metric Tonnes Per Year Of Hard-To-Recycle PET Household Packaging Waste
KINGSPORT, Tenn., Sept. 22, 2022 /PRNewswire/ -- Interzero and Eastman (NYSE:EMN) today announced a long-term supply agreement for Eastman's previously announced molecular recycling
Charles Schwab To Rally Around 20%? Here Are 5 Other Price Target Changes For Monday
Jefferies raised the price target on The Charles Schwab Corporation (NYSE: SCHW) from $78 to $86. Jefferies analyst Daniel Fannon maintained the stock with a Buy rating. Charles Schwab shares fell 0.5% to $71.50 in pre-market trading.
Wells Fargo Slashes Price Target On This Stock By Over 71%, Also Check Out Other Major PT Changes Here
Wells Fargo cut the price target on Cabaletta Bio, Inc. (NASDAQ: CABA) from $14 to $4. Wells Fargo analyst Derek Archila maintained the stock with an Overweight rating. Cabaletta Bio shares gained 0.9% to trade at $0.92 on Wednesday.